Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting 2020-11-10 22:30
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting 2020-11-09 21:12
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update 2020-11-09 21:00
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit 2020-11-09 20:30
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R) 2020-11-09 18:22
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim 2020-11-09 18:07
PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period 2020-11-05 21:00
Gracell Biotechnologies Announces Two Oral Presentations at the ASH Annual Meeting and Exposition 2020 2020-11-05 11:52
Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation 2020-11-04 20:00
Great Bay Bio Announces Its First AI-enabled Bioprocessing Platform-Klone 4.0, Reducing Cell Line Development Time and Cost by Up to 80% 2020-11-02 22:00
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19 2020-11-02 22:00
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates 2020-11-02 19:00
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development 2020-11-02 08:27
TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000 2020-11-02 07:30
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide 2020-10-29 20:00
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center 2020-10-29 08:38
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies 2020-10-28 21:00
Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
1 98 99 100 101 102 204